Vaccines & Immunology

mRNA platforms, boosters, monoclonals, and immune‑system science.

  • 18 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Vaccines & Immunology


bioengineer.org > tetraspanin-protein-supercharges-car-t-cells-by-amplifying-il-2-signaling

Tetraspanin Protein Supercharges CAR-T Cells by Amplifying IL-2 Signaling

24+ min ago   (95+ words) Chimeric antigen receptor T cell therapy has transformed the treatment of certain blood cancers, yet a persistent challenge has dogged the field from its earliest clinical successes: not every patient responds, and even among those who do, the engineered cells…...


bioengineer.org > ancient-viral-fossils-in-tumors-reveal-targets-that-drive-anti-metastatic-immunity-in-breast-cancer

Ancient Viral Fossils in Tumors Reveal Targets That Drive Anti-Metastatic

1+ hour, 4+ min ago   (639+ words) Endogenous retroviruses, the molecular remnants of ancient viral infections that have been embedded in the genomes of mammals for millions of years, have long been suspected of shaping how the immune system sees cancer....


bioengineer.org > scientists-map-how-tumours-push-immune-cells-into-exhaustion

Scientists Map How Tumours Push Immune Cells Into Exhaustion

1+ hour, 20+ min ago   (81+ words) Inside tumours, some of the body’s most powerful defenders gradually lose the ability to fight. These immune cells, known as T cells, are normally capable of recognizing and destroying cells that have turned cancerous. Yet when they remain in the…...


bioengineer.org > liquid-droplets-inside-cells-emerge-as-promising-new-targets-for-cancer-therapy

Liquid Droplets Inside Cells Emerge as Promising New Targets for Cancer

1+ hour, 21+ min ago   (700+ words) Inside every human cell, a quiet revolution in thinking about cellular organization has been gathering momentum, and it is now beginning to reshape how scientists approach cancer treatment....


digitaljournal.com > article > qa-advancing-cancer-biotech-therapies-with-a-multipronged-approach

Q&A: Advancing cancer biotech therapies with a multipronged approach

9+ hour, 50+ min ago   (562+ words) Op-Ed: Space weaponization could be an incredibly stupid, massive own goal for humanity Middle East cyber threats enter a new phase as ransomware surges and AI joins the attacker’s toolkit Canadian organizations are struggling to turn AI into ROI Foldable…...


note.com > happy_gerbil6727 > n > n1e7632afd470

WBS Activity Coding Structure Simplifies Primavera P6 Schedules|Himansi Kaur

1+ day, 23+ hour ago   (184+ words) In Primavera P6, activity code refers to a label which is assigned to an activity. This label is based on a specific classification. For example, a building project may contain activities for excavation, foundations, structural work, electrical installation, and finishing. Without…...


earth.com > science > tiny-particles-turn-a-tumors-own-immune-guards-against-it

Tiny particles turn a tumor’s own immune guards against it

1+ day, 4+ hour ago   (957+ words) Nanoparticles that reprogram a tumor's own macrophages drew killer T cells into mouse breast tumors, a new route for cancer immunotherapy. The immune system may be capable of attacking a tumor. Yet some of the most common cells inside a…...


scitechdaily.com > too-much-rna-can-drain-a-cells-energy-scientists-discover

Too Much RNA Can Drain a Cell’s Energy, Scientists Discover

1+ day, 11+ hour ago   (590+ words) A virus may cripple a cell’s power supply simply by producing too much of a molecule the cell needs to survive....


openpr.com > news > 4636057 > car-t-clinical-trial-pipeline-gains-momentum-180-companies

CAR-T Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

2+ day, 12+ hour ago   (60+ words) CAR-T Clinical Trial Pipeline Gains Momentum: 180+ Companies openPR.com CAR-T Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight Press release from: ABNewswire Permanent link to this press release: You can edit or delete your…...


gxpnews.net > en > 2026 > 09 > novosibirsk-firm-vector-bialgam-secures-patent-for-faster-hepatitis-a-vaccine-process

Novosibirsk firm Vector-BiAlgam secures patent for faster hepatitis A vaccine process | News

2+ day, 16+ hour ago   (286+ words) As the developers explained, existing methods lose up to 70–90% of antigen during purification, and its closest prototype – the Algavak vaccine – does not provide sufficient purification from cellular DNA and ballast proteins while maintaining the required antigen yield. According to them,…...